Non-steroidal anti-inflammatory drugs and ulcer complications: A risk factor analysis for clinical decision-making

被引:67
作者
Hansen, JM
Hallas, J
Lauritsen, JM
Bytzer, P
机构
[1] ODENSE UNIV,DEPT CLIN PHARMACOL,ODENSE,DENMARK
[2] ODENSE UNIV,DEPT EPIDEMIOL,ODENSE,DENMARK
关键词
case-control study; non-steroidal anti-inflammatory drugs; risk factor; ulcer complication;
D O I
10.3109/00365529609031975
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Use of non-steroidal anti-inflammatory drugs (NSAIDs) is recognized as an important cause of peptic ulcer complications. The aim of this nested case-control study was to identify risk factors for NSAID-related ulcer complications. Methods: Cases were consecutive NSAID users admitted with an ulcer complication (n = 118), and controls were a random sample of all NSAID users without ulcer complication identified by a pharmacoepidemiologic database (n = 540). Results: Ninety-four of 118 cases were interviewed, and 324 of 540 controls answered the questionnaire. Analysis showed no difference between included and non-included subjects. Risk factors for patients at start of NSAID therapy were high age: 60-75 years (odds ratio (OR), 3.5 (95% confidence interval (Cl), 1.8-7.1); >75 years (OR, 8.9 (4.3-18.3)); male sex (OR 1.7 (1.0-3.0)); ulcer history (OR 2.5 (1.2-5.1)); steroid treatment (OR 2.0 (0.8-4.6)); smoking (OR 1.6 (0.9-2.7)); and alcohol use (OR 1.8 (0.9-3.6)). Risk factors for patients receiving NSAID therapy were high age, male sex, ulcer history, smoking, and, furthermore, dyspepsia (OR 2.0 (1.0-4.2)), especially NSAID-related dyspepsia (OR 8.7 (4.0-18.9)). Risk was lower for patients treated more than 3 months. Conclusion: Risk measured from this design can be shown to correlate strongly with the rate difference, a measure that is more clinically relevant than conventional relative risk estimates. Strong risk factors for NSAID-related ulcer complication are high age, male sex, ulcer history, and dyspepsia related to the NSAID therapy. Avoiding NSAID therapy in these high-risk patients, whenever possible, might prevent many adverse events.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 19 条
[1]  
BEARDON PHG, 1989, Q J MED, V71, P497
[2]   THE IMPACT OF RESEARCH QUALITY AND STUDY DESIGN ON EPIDEMIOLOGIC ESTIMATES OF THE EFFECT OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON UPPER GASTROINTESTINAL-TRACT DISEASE [J].
BOLLINI, P ;
RODRIGUEZ, LAG ;
GUTTHANN, SP ;
WALKER, AM .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (06) :1289-1295
[3]   THE ASSOCIATION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS WITH UPPER GASTROINTESTINAL-TRACT BLEEDING [J].
CARSON, JL ;
STROM, BL ;
SOPER, KA ;
WEST, SL ;
MORSE, ML .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (01) :85-88
[4]   RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].
GABRIEL, SE ;
JAAKKIMAINEN, L ;
BOMBARDIER, C .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796
[5]   NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE AND INCREASED RISK FOR PEPTIC-ULCER DISEASE IN ELDERLY PERSONS [J].
GRIFFIN, MR ;
PIPER, JM ;
DAUGHERTY, JR ;
SNOWDEN, M ;
RAY, WA .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (04) :257-263
[6]   INDIVIDUAL UTILIZATION OF ANTIASTHMA MEDICATION BY YOUNG-ADULTS - A PRESCRIPTION DATABASE ANALYSIS [J].
HALLAS, J ;
HANSEN, NCG .
JOURNAL OF INTERNAL MEDICINE, 1993, 234 (01) :65-70
[7]  
Hansen J M, 1991, Ugeskr Laeger, V153, P1402
[8]   VARIABILITY IN THE RISK OF MAJOR GASTROINTESTINAL COMPLICATIONS FROM NONASPIRIN NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
HENRY, D ;
DOBSON, A ;
TURNER, C .
GASTROENTEROLOGY, 1993, 105 (04) :1078-1088
[9]   RELATION OF UPPER GASTROINTESTINAL-BLEEDING TO NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND ASPIRIN - A CASE-CONTROL STUDY [J].
HOLVOET, J ;
TERRIERE, L ;
VANHEE, W ;
VERBIST, L ;
FIERENS, E ;
HAUTEKEETE, ML .
GUT, 1991, 32 (07) :730-734
[10]   CURRENT PEPTIC-ULCER TIME TRENDS - AN EPIDEMIOLOGICAL PROFILE [J].
KURATA, JH ;
CORBOY, ED .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (03) :259-268